BIOCARDIA, INC. - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/90550.xml BIOCARDIA, INC. - Press Releases en xml@emediawire.com xml@emediawire.com 30 BioCardia and the University of Miami Receive FDA Clearance to Initiate Co-Sponsored Heart Failure Stem Cell Clinical Trial Comparing Two Cell Populations http://www.prweb.com/releases/2008/04/prweb904454.htm BioCardia, Inc., a regenerative medicine company, and the University of Miami today announced that the United States Food and Drug Administration approved a clinical investigation of two adult stem cell populations in the setting of heart failure. (PRWeb Apr 30, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb904454.htm

]]> http://www.prweb.com/releases/2008/04/prweb904454.htm BioCardia Completes $7.4 Million Private Equity Financing Following Successful Phase I Clinical Trial Enrollment and Two Year Followup Data http://www.prweb.com/releases/2008/04/prweb894564.htm BioCardia, Inc., a regenerative medicine company, today announced the completion of a new round of financing, raising $7.4 million from existing and new investors. (PRWeb Apr 27, 2008)

Read the full story at http://www.prweb.com/releases/2008/04/prweb894564.htm

]]> http://www.prweb.com/releases/2008/04/prweb894564.htm BioCardia Announces Completion of Enrollment of TABMMI Cardiac Stem Cell Trial http://www.prweb.com/releases/2008/03/prweb815494.htm BioCardia announces completion of enrollment in the Transendocardial Autologous Bone Marrow in Myocardial Infarction (TABMMI) trial with perfect procedural safety results in all twenty patients treated. The trial led by principle investigator Dr. Luis de la Fuente presented two year follow-up on the first ten patients at the CRT meeting in Washington in February supporting long term safety and the therapeutic benefit of this approach. (PRWeb Mar 31, 2008)

Read the full story at http://www.prweb.com/releases/2008/03/prweb815494.htm

]]> http://www.prweb.com/releases/2008/03/prweb815494.htm BioCardia, South San Francisco, CA and Symphony Medical, Eden Prairie, MN announce License, Development, and Commercialization Agreement http://www.prweb.com/releases/2005/01/prweb195465.htm BioCardia, Inc. and Symphony Medical, Inc. announce a mutually exclusive agreement for development and commercialization of a combination product that combines Symphony Medical's biotherapeutic technology and BioCardia device delivery technology for the treatment of cardiac conduction disorders. (PRWeb Jan 9, 2005)

Read the full story at http://www.prweb.com/releases/2005/01/prweb195465.htm

]]> http://www.prweb.com/releases/2005/01/prweb195465.htm